Health Care

Drugmaker paying $33M over recalled nonprescription meds

Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.

Anthem weighing ObamaCare exit as uncertainty grows

The CEO of the nation’s second largest health insurer, Anthem (NYSE:ANTM), said Wednesday the company was weighing whether to continue participating in the ObamaCare marketplace in 2018, as the deadline for insurers to register plans in most states approaches in less than a month.

TrumpCare under scrutiny: What to watch for in the CBO score

The Congressional Budget Office will release its score of the revised GOP health care effort to repeal and replace the Affordable Care Act Wednesday, an important analysis that could alter the path of the Trump administration’s health care legislation.